Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives
Multidrug resistance (MDR) presents a serious challenge to the efficiency of cancer treatment, and may be associated with the overexpression of drug efflux pumps. P-glycoprotein (P-gp) is a drug efflux pump often found overexpressed in cases of acquired MDR. Nevertheless, there are no P-gp inhibitor...
Saved in:
Main Authors: | Vanessa Lopes-Rodrigues (Author), Emília Sousa (Author), M. Helena Vasconcelos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
by: Gamal-Eldein Fat, et al.
Published: (2020) -
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
by: Yusuke Kono, et al.
Published: (2021) -
The Inhibitory Activity of Curcumin on P-Glycoprotein and Its Uptake by and Efflux from LS180 Cells Is Not Affected by Its Galenic Formulation
by: Sandra Flory, et al.
Published: (2021) -
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
by: Tripta Bansal, et al.
Published: (2009) -
Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment
by: Giovanna Cassone Salata, et al.
Published: (2022)